SEC Comment Letter 0000000000-25-000195 to Bionano Genomics, Inc. (BNGO)
Bionano Genomics, Inc.
Date: Jan. 8, 2025 · CIK: 0001411690 · Accession: 0000000000-25-000195
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-284124
Letter
January 8, 2025 R. Erik Holmlin, Ph.D. President and Chief Executive Officer Bionano Genomics, Inc. 9540 Towne Centre Drive, Suite 100 San Diego, California 92121 Re:Bionano Genomics, Inc. Registration Statement on Form S-3 Filed January 3, 2025 File No. 333-284124 Dear R. Erik Holmlin Ph.D.: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Margaret Sawicki at 202-551-7153 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc:Tom Coll, Esq.
Show Raw Text
January 8, 2025
R. Erik Holmlin, Ph.D.
President and Chief Executive Officer
Bionano Genomics, Inc.
9540 Towne Centre Drive, Suite 100
San Diego, California 92121
Re:Bionano Genomics, Inc.
Registration Statement on Form S-3
Filed January 3, 2025
File No. 333-284124
Dear R. Erik Holmlin Ph.D.:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Margaret Sawicki at 202-551-7153 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:Tom Coll, Esq.